Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients-Reference-Cited by-同舟云学术

Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients

Published:2018-01 Issue:1 Volume:26 Page:269-279
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Marcucci Katherine T.,Jadlowsky Julie K.,Hwang Wei-Ting,Suhoski-Davis Megan,Gonzalez Vanessa E.,Kulikovskaya Irina,Gupta Minnal,Lacey Simon F.,Plesa Gabriela,Chew Anne,Melenhorst J. Joseph,Levine Bruce L.,June Carl H.

Funder

Leukemia and Lymphoma Society

Takara Bio

Novartis Pharmaceuticals

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference40 articles.

1. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N. Engl. J. Med.,2014

2. Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial;Muul;Blood,2003

3. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia;Porter;Sci. Transl. Med.,2015

4. Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV;Tebas;Blood,2013

5. Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction;Rosenberg;N. Engl. J. Med.,1990

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of hepatic lentiviral vector transduction; implications for preclinical studies and clinical gene therapy protocols;2024-08-21

2. Sweet and sticky: increased cell adhesion through click-mediated functionalization of regenerative liver progenitor cells;2024-06-27

3. Engineering strategies to safely drive CAR T-cells into the future;Frontiers in Immunology;2024-06-19

4. Unraveling resistance mechanisms in anti-CD19 chimeric antigen receptor-T therapy for B-ALL: a novel in vitro model and insights into target antigen dynamics;Journal of Translational Medicine;2024-05-21

5. Direct in vivo CAR T cell engineering;Trends in Pharmacological Sciences;2024-05